Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Organon Pharma (UK) Limited. (Tel: 02081 593593).
Adverse events related to Emgality® (galcanezumab) should also be reported to Lilly: please call Lilly UK on 01256 315 000.
By clicking the above link you will leave the Organon website and be taken to the MHRA website.